Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abaxis Inc (NASDAQ:ABAX)

46.36
Delayed Data
As of Jul 22
 -8.39 / -15.32%
Today’s Change
37.71
Today|||52-Week Range
58.15
-16.74%
Year-to-Date
Abaxis (ABAX) Q1 Earnings Miss Estimates, Sales Up Y/Y
Jul 22 / Zacks.com - Paid Partner Content
Medical Product Earnings on Jul 21: ABAX, ATHN, NURO, SYK
Jul 20 / Zacks.com - Paid Partner Content
3 Stocks Dragging In The Drugs Industry
Jul 22 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close54.75
Today’s open49.50
Day’s range46.02 - 49.50
Volume1,097,571
Average volume (3 months)182,950
Market cap$1.0B
Dividend yield1.04%
Data as of 07/22/2016

Growth & Valuation

Earnings growth (last year)+57.46%
Earnings growth (this year)+1.76%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)+8.05%
P/E ratio34.1
Price/Sales4.74
Price/Book4.40

Competitors

 Today’s
change
Today’s
% change
INGNInogen Inc+0.01+0.02%
NVCRNovocure Ltd+0.05+0.42%
MMSIMerit Medical System...+0.29+1.34%
LMNXLuminex Corp-0.11-0.50%
Data as of 07/22/2016

Financials

Next reporting dateOctober 18, 2016
EPS forecast (this quarter)$0.36
Annual revenue (last year)$218.9M
Annual profit (last year)$31.1M
Net profit margin14.20%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Clinton H. Severson
President &
Chief Operating Officer
Donald Peter Wood
Corporate headquarters
Union City, California

Forecasts

Partner Offers

Search for Jobs